These companies focus on the research, development and commercialization of innovative drugs, therapies, and treatments. Investments can span various therapeutic areas, including oncology, neurology, infectious diseases, rare diseases, and more.

This category includes companies that develop cutting-edge tools, technologies, and platforms to accelerate scientific research and discovery. Investments can involve genomics, proteomics, gene editing, bioinformatics, laboratory automation, and other enabling technologies.

Investments in agricultural biotechnology aim to enhance crop yields, improve food quality, and develop sustainable farming practices. This can include genetically modified crops, precision agriculture technologies, agriculture biologics, and novel solutions for pest control, soil health and water conservation.

Investments in bioinformatics and data analytics leverage advanced computational tools and algorithms to derive insights from complex biological data. This can involve genomic data analysis, drug discovery optimization, clinical trial design, precision medicine, and personalized healthcare solutions.

Synthetic biology involves designing and engineering new biological systems, genetic circuits, and organisms with customized functionalities. Investments in synthetic biology can drive innovations in biofuel production, biomaterials, drug development, and sustainable manufacturing processes.